Regional sites
Landing page banner 1.png (1)


The trusted global leader in providing quicker and broader access to medicines.

At a Glance


Shaun Chilton, Group CEO

"COVID-19 had a continued impact on our markets leading to a decline in EBITDA compared to prior year.

The business continues to meet challenges head on with a significant number of business wins across both the Services and Products divisions, and the roll-out of key products Erwinase and Hunterase."


Annual Report 2021

Download the latest Annual Report and Accounts 2021.